← SynDRA
PARAXANTHINE
SynDRA canonical compound SYN0004186 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Mechanism of action | adenosine receptor antagonist |
Mechanisms of action (all sources)
- adenosine receptor antagonist
Cross-references
Synonyms
- Paraxanthine(72%)
- NSC-400018
- 1,7-Dimethylxanthine
- p-Xanthine
- 1,7-dimethyl-3H-purine-2,6-dione
- 1H-Purine-2,6-dione, 3,7-dihydro-1,7-dimethyl-
- 1,7-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione
- 1,7-Dimethyl-3,7-dihydro-1H-purine-2,6-dione
- NSC 400018
- Q3565Y41V7
- DTXCID2030853
- CHEBI:25858
- RefChem:417792
- 1,7-Dimethyl-1H-purine-2,6(3H,7H)-dione
- 3,7-Dihydro-1,7-dimethyl-1H-purine-2,6-dione
- Xanthine, 1,7-dimethyl-
- Caffeine Impurity F
- MFCD00005727
- 1,7-dimethyl-Xanthine
- Caffeine Impurity 5
- Caffeine EP Impurity F
- EINECS 210-271-9
- BRN 0197907
- UNII-Q3565Y41V7
- PXT
- 1,7-Dimethyl-1H-purine-2,6-dione
- Paraxanthine (Standard)
- Spectrum2_001733
- Spectrum3_000774
- Spectrum4_001207
- Spectrum5_001506
- Lopac-D-5385
- Lopac0_000389
- BSPBio_002448
- KBioGR_001614
- 5-26-13-00554 (Beilstein Handbook Reference)
- MLS000859929
- DivK1c_000081
Look up PARAXANTHINE in the interactive SynDRA portal →